The CU Anschutz Cancer Center's Cancer Research Experience for Undergraduates (CREU) and Summer Undergraduate Research Fellowship (SURF) have completed their 2026 cohort! Learn more about these fun hands-on programs: https://bit.ly/4fyG8zm

Congrats to all 43 of our members who made the 2026 5280 Magazine Top Doctors list! 🏆 ⭐ See the full list of @cumedicalschool.bsky.social Top Doctors here: https://news.cuanschutz.edu/medicine/5280-magazine-top-doctors-for-2026

After an esophageal cancer diagnosis, Don McCoy avoided surgery and chemotherapy thanks to innovative treatment from cancer center member Sunnie Kim, MD. Read his story: https://bit.ly/3TropmA

CU Anschutz Cancer Center's Laura Graham, MD, saw an increase from 30% to 72% of eligible patients getting tested for prostate cancer under a new approach ⬇️ https://news.cuanschutz.edu/cancer-center/onsite-genetic-testing-prostate-cancer

Onsite Genetic Testing Leads to Better Testing Rates for Colorado Patients with Prostate Cancer

A new approach to genetic testing for patients with prostate cancer is leading to an increase in testing for those who qualify.

news.cuanschutz.edu

#WorldHeadAndNeckCancerDay: CU Anschutz Cancer Center's Carissa Thomas, MD, PhD, FACS, shares the truth about these head and neck cancer myths: https://bit.ly/4fjkwsp

At the 2026 American Urological Association Annual Meeting, CU Anschutz Cancer Center's Janet Kukreja, MD, MPH, spoke with Leslie Ballas, MD, and Ashish Kamat, MD, MBBS, about bladder cancer radiation toxicity management: https://bit.ly/3Twa3Bh

2026 Courage Classic: Interim Director James DeGregori, PhD, was among the nearly 400 participants, which included fellow @cuanschutz.bsky.social faculty, family, friends, caregivers, and cancer survivors who made up the Wheels of Justice team.

#SarcomaCancerAwarenessMonth: A ‘homegrown’ clinical trial led by Breelyn Wilky, MD, at the CU Anschutz Cancer Center was a lifesaver for cardiac sarcoma patient Peter Wessel: https://bit.ly/4x0bG8Z

In this Q&A, CU Anschutz Cancer Center member Urs Weber, MD, walks us through a family of focused treatments that can block or slow cancer’s growth: https://news.cuanschutz.edu/cancer-center/targeted-cancer-therapies-explained

$100,000 will be matched through World Lung Cancer Day (8/1)! Consider making a gift today to the Ross Camidge (@drcamidge.bsky.social), MD, PhD, Thoracic Oncology Endowed Program Support Fund: https://bit.ly/4wLhXFe

Behind every scientific breakthrough is collaboration. Patricia Ernst, PhD, discusses how her program helps connect researchers to improve patient outcomes. Watch the full interview here: youtu.be/TbJMBaeK1lo?...

Lavanya Kondapalli, MD, is overseeing a CU Anschutz Cancer Center clinical trial that looks to treat myocarditis caused by checkpoint inhibitors: https://news.cuanschutz.edu/cancer-center/clinical-trial-myocarditis-caused-by-checkpoint-inhibitors

Michael Verneris, MD, is a physician-scientist whose work is driven by a commitment to solving the challenges patients face. See the full interview here: www.youtube.com/watch?v=kd2HLY7VRTw

Congratulations to Bradley Corr, MD! Corr has been named the CU Anschutz Cancer Center's deputy associate medical director of the Cancer Clinical Trials Office (CCTO). See the full announcement here: https://bit.ly/4f8Gay3

Imogene first arrived at Children’s Hospital Colorado as a teenager dealing with severe illness. With the help of a dedicated care team, she found healing and eventually a new sense of purpose that brought her back as a medical researcher through the CREU program: https://bit.ly/4w05FJq

CU Anschutz Cancer Center's Jenny Xiang, MD, talks about the basics of chemotherapy including how the treatment works, the side effects, and when patients typically receive it: https://news.cuanschutz.edu/cancer-center/basics-of-chemotherapy

CU Anschutz Cancer Center's Christine Conageski, MD, MSc, says gynecologists should be trained to screen for anal cancer, which is rising in incidence in older women: https://bit.ly/4vRSlX6

The work of James Costello, PhD, and a multidisciplinary science team is backed by a two-year ASPIRE grant from the CU Anschutz Cancer Center and @cumedicalschool.bsky.social: https://bit.ly/3Qw8CSv

Sarcoma Awareness Month: Masanori Hayashi, MD, shared the latest on his research into BCOR-CCNB3 sarcomas (BCS), a subtype of small cell sarcomas: https://bit.ly/4oUtrnn

Ajay Major (@majorajay.bsky.social), MD, MBA, is the lead author of a new study that evaluates the time burdens that cancer therapies impose on patients in connection with new therapies for both slow-growing and aggressive lymphomas: https://bit.ly/3SkYAEj

At last week's Research Roadshow, participants spoke with CU Anschutz Cancer Center leaders, members, and staff about cancer prevention, new treatments, research, and clinical trials. Learn more about Research Roadshows: https://bit.ly/3SzyP33

When cancer metastasizes, it increases the risk of mortality. To fight this, CU Anschutz Cancer Center leader Heide Ford, PhD, and her lab are studying how cancer metastasizes in the first place. Learn more about this research and Ford's career: https://bit.ly/43Ug3Wn

Kayla Calkin rides waves of emotions after an invasive ductal breast cancer diagnosis at 36 while trying to start a family: https://bit.ly/4oH2TWu

Challenging the standard of care for melanoma brain metastases, CU Anschutz neurosurgeon Robert Breeze, MD, pursued aggressive treatment options that are now commonplace. Learn about how treatment has changed and the melanoma clinical trials offered here at the Cancer Center: https://bit.ly/4f1CAa9

CU Anschutz Cancer Center's Theresa Pacheco, MD, says bemotrizinol, a newly FDA-approved chemical filter that blocks the sun’s rays, offers protection against both damaging UVA and UVB light ⬇️ https://bit.ly/4ouiubG

Newly Approved Sunscreen Ingredient Promises ‘Broad, Reliable’ Protection

A sunscreen ingredient that offers safe, long-lasting protection has been OK'd for use in the U.S. A CU Anschutz dermatologist applauds the decision.

news.cuanschutz.edu

CU Anschutz Cancer Center member and radiation oncologist Brian Kavanagh, MD, MPH, talks about radiation therapy treatment, its side effects, and recent advances: https://bit.ly/4uAb4Ff

After five years of reviewing and understanding how work affects cancer treatment, the WeCanWork program is now equipping clinicians to support patients who keep working through cancer: https://bit.ly/44cqaGe

At the @ascocancer.bsky.social Annual Meeting, Manali Kamdar, MD, shared long-term safety data on liso-cel, which demonstrated sustained tolerability, support for outpatient care, and increased patient access ⬇️ https://news.cuanschutz.edu/cancer-center/car-t-therapy-asco-2026-findings

Building Confidence in CAR T Therapy: CU Anschutz Showcases ASCO 2026 Findings from Manali Kamdar, MD

CY Anschutz Cancer Center researchers' ASCO 2026 data show that liso-cel CAR T has durable safety, low long-term risks, and supports outpatient care for patients with large B-cell lymphoma.

news.cuanschutz.edu

The U.S. News & World Report has released its 2026-2027 Best Global Universities rankings. We're proud of our oncologists for their tireless efforts in the fight against cancer. This ranking of the @cuanschutz.bsky.social reflects their work: https://bit.ly/3QLegA3

One of the biggest lessons Michael Verneris, MD, has learned as a leader is to lead by example and keep patients at the center of every decision. Watch the full interview: www.youtube.com/watch?v=kd2H...